EXHIBIT 99.1
Published on August 27, 2021
Exhibit 99.1
VIA SEDAR
August 27, 2021
Autorité des marchés financiers
Alberta Securities Commission
British Columbia Securities Commission
Manitoba Securities Commission
Ontario Securities Commission
Subject: | Acasti Pharma Inc. (the “Corporation”) |
Report on the Voting Results, in accordance with article 11.3 of Regulation 51-102 respecting Continuous Disclosure Obligations (“Regulation 51-102”) |
Following the annual and special meeting of shareholders of the Corporation held on August 26, 2021 (the “AGM”), this report presents the items voted on during the AGM and the corresponding voting results, in accordance with article 11.3 of Regulation 51-102. For more detailed information on the proposals submitted to shareholders, please refer to the management information circular and proxy statement of the Corporation dated July 15, 2021 (the “Circular”).
According to the scrutineer’s reports, being present in person or by proxy, were the holders of 75,679,548 common shares, or 36.32%, of the 208,375,549 common shares issued and outstanding on July 14, 2021, the record date for the AGM.
The following individuals were elected as directors of Acasti at its AGM: Roderick N. Carter, Jean-Marie (John) Canan, Jan D’Alvise, Donald Olds, William A. Haseltine and Vimal Kavuru.
1. Ordinary resolution approving the issuance of common share necessary to complete the transactions contemplated by the merger agreement, as more particularly described in the Circular
Votes Cast For | % Votes Cast For | Votes Cast Against | % Votes Cast Against |
21,915,935 | 90.82% | 2,024,031 | 8.39% |
2. Election of the directors of the Corporation for the ensuing year
Nominee | Votes For | % Votes For | Votes Withheld | % Votes Withheld |
Roderick N. Carter | 21,898,808 | 90.75% | 2,232,592 | 9.25% |
Jean-Marie (John) Canan | 21,787,291 | 90.29% | 2,344,109 | 9.71% |
Jan D’Alvise | 22,258,065 | 92.24% | 1,873,335 | 7.76% |
Donald Olds | 21,802,345 | 90.35% | 2,329,055 | 9.65% |
3. Election of William A. Haseltine and Vimal Kavuru as directors of the Corporation for the ensuing year, conditional upon and to be effective only at the closing of the merger, as provided for in the merger agreement
Nominee | Votes For | % Votes For | Votes Withheld | % Votes Withheld |
William A. Haseltine | 22,397,309 | 92.81% | 1,734,090 | 7.19% |
Vimal Kavuru | 22,302,490 | 92.42% | 1,828,909 | 7.58% |
4. Appointment of KPMG LLP as auditors for the ensuing year and to authorize the board of directors of the Corporation (the “Board”) to fix their remuneration
Votes Cast For | % Votes Cast For | Votes Cast Against | % Cast Votes Against |
73,715,107 | 97.49% | 1,024,711 | 1.36% |
5. Ordinary resolution approving an advisory (non-binding) resolution approving the compensation of our named executive officers, as more particularly described in the Circular
Votes Cast For | % Votes Cast For | Votes Cast Against | % Votes Cast Against |
19,499,771 | 80.81% | 3,938,689 | 16.32% |
6. Ordinary resolution approving, ratifying and confirming certain amendments to the Corporation’s stock option plan, as more particularly described in the Circular
Votes Cast For | % Votes Cast For | Votes Cast Against | % Votes Cast Against |
18,395,569 | 76.87% | 4,588,149 | 19.17% |
(Disinterested Shareholders only – 197,500 shares are excluded)
7. Ordinary resolution approving, ratifying and confirming certain amendments to the Corporation’s equity incentive plan, as more particularly described in the Circular
Votes Cast For | % Votes Cast For | Votes Cast Against | % Votes Cast Against |
18,407,325 | 76.91% | 4,642,496 | 3.77% |
(Disinterested Shareholders only – 197,500 shares are excluded)
8. Ordinary resolution approving, an advisory (non-binding) resolution to amend the articles of the Corporation, to effect a reverse stock split of the Corporation’s common shares, with a 1-8 ratio, as more particularly described in the Circular
Votes Cast For | % Votes Cast For | Votes Cast Against | % Votes Cast Against |
13,248,244 | 54.90% | 10,064,376 | 41.71% |
Sincerely,
/s/ Jan D’Alvise
Jan D’Alvise
Chief Executive Officer